Skip to content

Clinical trials

Phase 3 trials in Hong Kong with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Unknown status Country / region: Hong Kong Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20081
20091
20111
20121
20131
20151
20162
20174
20192
20203
20211
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong7
The University of Hong Kong6
Queen Mary Hospital, Hong Kong3
Kwong Wah Hospital2
Belinda Howe1
China National Biotec Group Company Limited1
European Organisation for Research and Treatment of Cancer - EORTC1
Lymphoma Trials Office1
National Taiwan University Hospital1
National University Hospital, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis2
Rectal Neoplasms2
Sepsis2
Stomach Neoplasms2
Adenocarcinoma1
Bone Diseases, Metabolic1
COVID-191
Cerebral Hemorrhage1
Colonic Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.